Inventor · disambiguated record
Udo Lange
Also filed as: LANGE UDO · LANGE UDO E W
49 granted patents·18 pending applications·361 citations·filing 1987–2024
98Inventor score
Top patents by PatentIndex Score
67 records- 0194US8431604B2Guanidine compounds, and use thereof as binding partners for 5-HT5 receptorsNETZ ASTRID·Filed 2005·Granted Apr 30, 2013·35 cites·12 claims
- 0293US8642587B2Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapyLANGE UDO·Filed 2010·Granted Feb 4, 2014·62 cites·19 claims
- 0390US8481576B2Guanidine compounds, and use thereof as binding partners for 5-HT5 receptorsNETZ ASTRID·Filed 2011·Granted Jul 9, 2013·16 cites·12 claims
- 0488US8653100B2Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapyOCHSE MICHAEL·Filed 2009·Granted Feb 18, 2014·17 cites·20 claims
- 0588US8563617B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyAMBERG WILHELM·Filed 2010·Granted Oct 22, 2013·13 cites·21 claims
- 0688US8440694B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2012·Granted May 14, 2013·12 cites·13 claims
- 0786US8686002B2Heterocyclic compounds and their use as binding partners for 5-HT5 receptorsAMBERG WILHELM·Filed 2006·Granted Apr 1, 2014·5 cites·29 claims
- 0884US4754807ASand screen for production oil wellsOTIS ENG CO·Filed 1987·Granted Jul 5, 1988·52 cites·4 claims
- 0980US10556907B2Fused heterocyclic compounds as S1P modulatorsABBVIE INC·Filed 2016·Granted Feb 11, 2020·5 cites·12 claims
- 1080US7790727B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2008·Granted Sep 7, 2010·4 cites·31 claims
- 1179US9656955B2Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted May 23, 2017·2 cites·20 claims
- 1278US7105508B1Integrin receptors antagonistsABBOTT GMBH & CO KG·Filed 2000·Granted Sep 12, 2006·15 cites·3 claims
- 1376US6072085AImine hydrosilylation, uses and reagents related theretoMASSACHUSETTS INST TECHNOLOGY·Filed 1997·Granted Jun 6, 2000·19 cites·24 claims
- 1475US7491729B23-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereofABBOTT GMBH & CO KG·Filed 2003·Granted Feb 17, 2009·9 cites·18 claims
- 1574US8921406B25-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptorsAMBERG WILHELM·Filed 2006·Granted Dec 30, 2014·1 cites·23 claims
- 1674US8242102B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Aug 14, 2012·2 cites·23 claims
- 1773US7125883B1Integrin receptor ligandsABBOTT GMBH & CO KG·Filed 2000·Granted Oct 24, 2006·9 cites·2 claims
- 1872US9096619B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Aug 4, 2015·1 cites·20 claims
- 1971US8957089B2Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 17, 2015·1 cites·15 claims
- 2071US2025296917A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 2169US6740647B1Thrombin inhibitorsABBOTT GMBH & CO KG·Filed 1999·Granted May 25, 2004·29 cites·14 claims
- 2269US6440937B1Dipeptide benzamidine as a kininogenase inhibitorABBOTT LAB·Filed 1997·Granted Aug 27, 2002·27 cites·16 claims
- 2368US8846743B2Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyPOHLKI FRAUKE·Filed 2011·Granted Sep 30, 2014·1 cites·19 claims
- 2468US8507469B2Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorSCHULTZ THOMAS·Filed 2008·Granted Aug 13, 2013·2 cites·44 claims
- 2568US7279468B2Integrin ligandsABBOTT GMBH & CO KG·Filed 2001·Granted Oct 9, 2007·4 cites·16 claims
- 2667US8877794B2Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyPOHLKI FRAUKE·Filed 2011·Granted Nov 4, 2014·1 cites·18 claims
- 2767US8853196B2Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyAMBERG WILHELM·Filed 2012·Granted Oct 7, 2014·1 cites·14 claims
- 2866US9051280B2Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapyLANGE UDO·Filed 2012·Granted Jun 9, 2015·1 cites·20 claims
- 2966US8883839B2Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapyPOHLKI FRAUKE·Filed 2011·Granted Nov 11, 2014·1 cites·19 claims
- 3066US8846741B2N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2012·Granted Sep 30, 2014·1 cites·19 claims
- 3161US2010210664A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2008·Application pending·0 cites
- 3261US2015175570A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 3361US2015183770A15-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptorsABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 3459US9586945B2Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 7, 2017·0 cites·21 claims
- 3559US9586942B2Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 7, 2017·0 cites·20 claims
- 3659US2014221371A1Heterocyclic compounds and their use as binding partners for 5-ht5 receptorsABBVIE DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 3759US2014200224A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorABBVIE DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 3858US9475782B2Guanidine compounds, and use thereof as binding partners for 5-HT5 receptorsABBVIE DEUTSCHLAND·Filed 2012·Granted Oct 25, 2016·0 cites·3 claims
- 3958US8293913B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Oct 23, 2012·0 cites·13 claims
- 4058US2019290632A1Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 4158US2019290645A1Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 4257US9067871B2Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2013·Granted Jun 30, 2015·0 cites·6 claims
- 4355US2017037016A1Guanidine compounds and use thereof as binding partners for 5-ht5 receptorsABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 4454US9238619B2Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Jan 19, 2016·0 cites·26 claims
- 4554US9227930B2Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBOTT LAB·Filed 2014·Granted Jan 5, 2016·0 cites·19 claims
- 4653US6114358AThrombin inhibitorsBASF AG·Filed 1997·Granted Sep 5, 2000·11 cites·16 claims
- 4753US2011319421A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2011·Application pending·0 cites
- 4852US8492540B21,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorBRAJE WILFRIED·Filed 2008·Granted Jul 23, 2013·0 cites·20 claims
- 4952US2017172993A1Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 5052US2017173009A1Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →